Chang Xu
- Aging top 10%
- Pathology and Forensic Medicine top 10%
- Spinal Cord Injury Research 12
- Neurology top 10%
- Neuroinflammation and Neurodegeneration Mechanisms 4
-
- Nanoplatforms for cancer theranostics 3
-
- Autophagy in Disease and Therapy 6
-
- Hepatocellular Carcinoma Treatment and Prognosis 3
-
- Probiotics and Fermented Foods 3
-
- Inflammasome and immune disorders 3
-
- MicroRNA in disease regulation 2
- Co-authors
- Xifan MeiSen LinHe TianJiaquan LinYang BaiZongrui TongZhongquan SunWeilin Wang
- Journals
- Materials & Design (3 papers)CNS Neuroscience & Therapeutics (2 papers)Biological and Pharmaceutical Bulletin (2 papers)
- Partner nations
- ChinaTaiwanSouth Korea
In The Last Decade
Chang Xu
33 papers receiving 726 citations
Peers
Comparison fields: 5 of 94
- Aging 30
- Pathology and Forensic Medicine 163
- Neurology 65
- Biomaterials 90
- Biomedical Engineering 199
Countries citing papers authored by Chang Xu
This map shows the geographic impact of Chang Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang Xu more than expected).
Fields of papers citing papers by Chang Xu
This network shows the impact of papers produced by Chang Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang Xu. The network helps show where Chang Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chang Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 32 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 4 | |
| 9 | 2023 | 1 | |
| 10 | 2022 | 18 | |
| 11 | 2022 | 20 | |
| 12 | 2022 | 17 | |
| 13 | 2022 | 9 | |
| 14 | 2021 | 20 | |
| 15 | 2021 | 9 | |
| 16 | 2021 | 26 | |
| 17 | 2021 | 19 | |
| 18 | 2020 | 75 | |
| 19 | 2017 | 7 | |
| 20 | 2014 | 53 |
About Chang Xu
Chang Xu is a scholar working on Pathology and Forensic Medicine, Aging, Neurology, Biological Psychiatry and Hepatology, having authored 35 papers that have together received 732 indexed citations. Recurring topics across this work include Spinal Cord Injury Research (12 papers), Autophagy in Disease and Therapy (6 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers), Nanoplatforms for cancer theranostics (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Probiotics and Fermented Foods (3 papers), Inflammasome and immune disorders (3 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Aging (30 citations), Pathology and Forensic Medicine (163 citations), Neurology (65 citations), Biomaterials (90 citations) and Biomedical Engineering (199 citations). Chang Xu has collaborated with scholars based in China, Taiwan and South Korea. Frequent co-authors include Xifan Mei, Sen Lin, He Tian, Jiaquan Lin, Yang Bai, Zongrui Tong, Zhongquan Sun, Weilin Wang, Hao Xu and Liuzhi Zhou. Their work appears in journals such as Materials & Design, CNS Neuroscience & Therapeutics, Biological and Pharmaceutical Bulletin, International Immunopharmacology and Neurochemical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.